Tranzipeg - a drug from the group of osmotic laxatives action. The product contains the active ingredient - macrogol. Tranzipeg is not absorbed from the gastrointestinal tract. The mechanism of action of the drug is its ability to retain water, thereby thinning occurs stool and facilitate their evacuation. Tranzipeg indirectly affect peristalsis, without causing irritating.  Tranzipeg 5, 9 g

Release form of the drug

The drug Tranzipeg available in powder for solution for oral white (there may be yellow and green particles), or almost white, with the scent of apple or lemon. After dissolution, the drug formed clear or slightly opalescent solution. In one pod (sachet) contains 2, 95 or 5, 9 g of macrogol.

Indications Tranzipega

According to the instructions Tranzipegu, indication for use of this drug is symptomatic treatment of constipation.


According to the instructions assigned Tranzipeg adult patients on 1-2 sachets per day (preferably in the morning). The entire daily dose is taken at one time. The maximum daily dosage Tranzipega - 11 8 The required amount of the drug to dissolve in 100 ml water.

The dosage for children aged 1-6 1-2 sachets (2, 95 g) per day. The maximum daily dosage - 5, 9, the drug has to be dissolved in 50 ml of water.

The maximum daily dose for children 6-12 years - 8, '85 dissolved in 50 ml of water.

Side effects Tranzipega

With proper application and compliance with dosage of this drug is quite well tolerated. This is also Tranzipege reviews from patients. Rarely observed the emergence of abdominal pain, nausea, vomiting, bloating, diarrhea and allergic reactions: rash, pruritus, angioedema.

Contraindications Tranzipega

The instructions to Tranzipegu contain the following contraindications:

  • severe pathology of the small and large intestine (obstruction, perforation of the intestinal wall, severe inflammatory bowel pathology expressed by stretching the colon);
  • pain in the abdominal cavity of unknown origin;
  • dehydration;
  • Crohn's disease, ulcerative colitis;
  • chronic heart failure, decompensated;
  • phenylketonuria (of the drug include aspartame);
  • individual intolerance of components.

Use of the drug during pregnancy Tranzipeg

Tranzipeg during pregnancy and lactation may be used by a physician. According to data from clinical studies, the drug has no teratogenic effects.

Use of the drug in children Tranzipeg

Tranzipeg drug successfully used in pediatric patients in the age of 1 year.


If overdose occurs Tranzipeg diarrhea stopped after 24-48 hours after discontinuation of the drug. To correct symptoms of overdose requires temporary cancellation or reduction in dose.


Preparation Tranzipeg contains sugar calories, it can therefore be used by patients suffering from diabetes. Tranzipeg not subject to enzymatic cleavage.  Tranzipeg 2 95 g

Before using this drug, especially in the case of constipation, accompanied by pain, fever and other symptoms, you should consult with your doctor.

The product contains sodium Tranzipeg that should be considered when salt-free diet.

The product also contains potassium, which must be considered when conditions requiring calculation of daily consumption of potassium.

The preparation Tranzipeg includes aspartame, which is a source of phenylalanine, therefore the drug is not suitable for phenylketonuria.

Interaction Tranzipega with other drugs

Tranzipeg delays absorption assignable simultaneously with drugs, therefore taken 2 hours after the consumption of other drugs.

Storage conditions

The drug Tranzipeg should be stored at room temperature out of reach of children.

Reviews Tranzipege

Due to its high efficiency and sufficient drug safety reviews of Tranzipege by physicians positive. This is facilitated by the ability to assign Tranzipeg during pregnancy.

Reviews Tranzipege by patients also showed good effect and light enough tolerability of the drug.